CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 199 filers reported holding CLOVIS ONCOLOGY INC in Q3 2015. The put-call ratio across all filers is 0.94 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,630,000 | -36.1% | 2,209,700 | -3.4% | 0.00% | -20.0% |
| Q2 2022 | $4,119,000 | +39.7% | 2,288,300 | +56.7% | 0.01% | +66.7% |
| Q1 2022 | $2,949,000 | +78.3% | 1,459,900 | +139.2% | 0.00% | +50.0% |
| Q4 2021 | $1,654,000 | +218.1% | 610,400 | +423.1% | 0.00% | +100.0% |
| Q3 2021 | $520,000 | -58.8% | 116,700 | +37.5% | 0.00% | 0.0% |
| Q2 2019 | $1,262,000 | -90.7% | 84,900 | -67.1% | 0.00% | -85.7% |
| Q2 2018 | $13,622,000 | 0.0% | 258,000 | 0.0% | 0.01% | -53.3% |
| Q1 2018 | $13,622,000 | -55.4% | 258,000 | -20.9% | 0.02% | -61.5% |
| Q2 2017 | $30,542,000 | +212.7% | 326,200 | +112.6% | 0.04% | +178.6% |
| Q1 2017 | $9,767,000 | +167.8% | 153,400 | +86.8% | 0.01% | +133.3% |
| Q4 2016 | $3,647,000 | -13.5% | 82,100 | -73.3% | 0.01% | -25.0% |
| Q2 2016 | $4,215,000 | -57.4% | 307,200 | -40.4% | 0.01% | -57.9% |
| Q1 2016 | $9,896,000 | -16.5% | 515,400 | +299.8% | 0.02% | -32.1% |
| Q3 2015 | $11,854,000 | +1087.8% | 128,900 | +485.9% | 0.03% | +833.3% |
| Q3 2014 | $998,000 | +15.6% | 22,000 | +54.9% | 0.00% | +50.0% |
| Q3 2013 | $863,000 | -39.8% | 14,200 | -33.6% | 0.00% | -50.0% |
| Q2 2013 | $1,433,000 | – | 21,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |